Offerings // Enveric Biosciences, Inc.

ENVB offering history

Every offering-related filing in Enveric Biosciences, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 1,000 filings back to Jul 30, 2001.

Last executed offering
Jun 9, 2026
424B5 — priced deal (shares or notes)
Last registration (announced)
Apr 23, 2026
S-3 — capacity, not a sale
Executed, last 12 months
6
424B pricings + 8-K 3.02 sales
Registered, last 12 months
4
S-1/S-3/F-series registrations
DateFilingWhat it means
Jun 9, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 29, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Apr 29, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Apr 23, 2026S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Apr 20, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Feb 18, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Feb 17, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Feb 10, 2026S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Feb 6, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 28, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 28, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Dec 31, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Dec 30, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 22, 2025S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Dec 12, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Dec 10, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Dec 8, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 5, 2025S-3/A →REGISTEREDS-3/A registration — capacity to sell shares, not a sale yet
Sep 29, 2025S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Sep 18, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Apr 17, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Apr 10, 2025S-3/A →REGISTEREDS-3/A registration — capacity to sell shares, not a sale yet
Feb 3, 2025424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Jan 30, 2025S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jan 30, 2025S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Jan 30, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jan 14, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Sep 12, 2024424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Sep 11, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 4, 2024S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Jul 8, 2024S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
May 3, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 11, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 24, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jan 22, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jan 11, 2024S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Dec 29, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Dec 6, 2023424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Dec 5, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 1, 2023S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
ENVB offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full ENVB workspace →
ENVB offering FAQ

When did ENVB last execute an offering?

Per SEC filings, Enveric Biosciences, Inc.'s most recent priced offering document is a 424B5 filed 2026-06-09. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did ENVB last announce or register an offering?

The most recent registration is a S-3 filed 2026-04-23. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.